Condition: Alzheimer Disease · Alzheimer Disease 1 · Alzheimer Disease 2 · Sponsor: Cognito Therapeutics, Inc.
This is a randomized, double-blind, sham-controlled pivotal study of sensory stimulation in subjects with mild to moderate AD. Up to approximately 670 subjects will be treated with either Active or Sham investigational device, Spectris™ AD, for 60 minutes daily for approximately 12 months. Efficacy will be measured using the Integrated Alzheimer's Disease Mini-Mental State Exam (MMSE) Activities of Daily Living (ADCS-ADL) Rating Scale (iADMARS).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| CCT Research - Gilbert Neurology Partners | Gilbert, Arizona, United States | — |
| Barrow Neurological Institute | Phoenix, Arizona, United States | — |
| CCT Research - Foothills Research Center | Phoenix, Arizona, United States | — |
| Banner Sun Health Research Institute | Sun City, Arizona, United States | — |
| Advanced Research Center, Inc | Anaheim, California, United States | — |
| ATP Clinical Research, Inc. | Costa Mesa, California, United States | — |
| Neurology Center of North Orange County | Fullerton, California, United States | — |
| Syrentis Clinical Research | Santa Ana, California, United States | — |
| Office of Elizabeth Zarate-Rowell, MD | Seal Beach, California, United States | — |
| Mile High Research Center | Denver, Colorado, United States | — |
| JEM Research Institute | Atlantis, Florida, United States | — |
| Visionary Investigators Network- Aventura | Aventura, Florida, United States | — |
+ 56 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.